|
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid |
|
CHEBI:140272 |
|
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid |
|
A docosanoid that is (14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid carrying three hydroxy substituents at positions 7, 16 and 17. An intermediate of specialised proresolving mediators |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Bijay
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C22H34O5/c1-2-3-9-16-20(24)21(25)17-12-7-5-4-6-10-14-19(23)15-11-8-13-18-22(26)27/h3-7,9-10,12,14,17,19-21,23-25H,2,8,11,13,15-16,18H2,1H3,(H,26,27)/b6-4?,7-5?,9-3-,14-10?,17-12+ |
LDVCZYSUILUYKN-OSLFFFSGSA-N |
C(=CC=C/C=C/C(C(C/C=C\CC)O)O)C=CC(CCCCCC(O)=O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
|
|
View more via ChEBI Ontology
Outgoing
|
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid
(CHEBI:140272)
has role
human xenobiotic metabolite
(CHEBI:76967)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid
(CHEBI:140272)
has role
specialised pro-resolving mediator
(CHEBI:140399)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid
(CHEBI:140272)
is a
docosanoid
(CHEBI:131863)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid
(CHEBI:140272)
is a
hydroxy polyunsaturated fatty acid
(CHEBI:140345)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid
(CHEBI:140272)
is conjugate acid of
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate
(CHEBI:140416)
|
|
Incoming
|
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate
(CHEBI:140416)
is conjugate base of
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid
(CHEBI:140272)
|
(14E,19Z)-7,16,17-trihydroxydocosa-8,10,12,14,19-pentaenoic acid
|
7,16,17-trihydroxy-(8,10,12,14E,19Z)-docosapentaenoic acid
|
ChEBI
|
7,16,17-trihydroxy-omega3-docosapentaenoic acid
|
ChEBI
|
resolvin D2n-3 DPA
|
ChEBI
|
RvD2n-3 DPA
|
SUBMITTER
|
23736886
|
PubMed citation
|
Europe PMC
|
28356517
|
PubMed citation
|
Europe PMC
|
28408222
|
PubMed citation
|
Europe PMC
|
|